Clinical Trial Update: Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency Disease [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating donor stem cell transplantation in young patients with congenital amegakaryocytic thrombocytopenia, leukemia, myelodysplastic syndromes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Amegakaryocytic Thrombocytopenia
• Congenital Neutropenia
• Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: University of California, San Francisco | Conditions: Congenital Amegakaryocytic Thrombocytopenia, Leukemia | Phase 1 | Status: COMPLETED